Earnings Preview: Usana Health Sciences
Portfolio Pulse from Benzinga Insights
Usana Health Sciences (NYSE:USNA) is scheduled to release its quarterly earnings report on February 6, 2024, with analysts estimating an EPS of $0.52. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Shares have been trading at $47.23 as of February 2, reflecting a 21.77% decline over the last 52 weeks. Investors are likely focused on both the reported earnings and the company's future guidance.
February 05, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Usana Health Sciences is expected to report an EPS of $0.52 for the upcoming quarter. Historical performance shows significant stock price movements post-earnings announcements. With shares currently down 21.77% YTD, the upcoming earnings and guidance will be crucial for investor sentiment.
Given Usana Health Sciences' mixed past earnings performance and the significant stock price reaction to earnings misses or beats, the upcoming earnings report could maintain the current stock price or induce volatility, depending on whether they meet, miss, or exceed expectations. The 21.77% YTD decline indicates that investor sentiment has been bearish, making the guidance provided in the earnings call particularly impactful.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100